NCT04323722Completed
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
Source: ClinicalTrials.gov · Last updated 23 Jun 2026
Brief summary (registry, in English)
This trial is assessing how Bladder filling variations and thus mesorectal movements are less when radiotherapy treatment is received with an empty bladder in rectal cancer
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 53 (actual)
- First submitted
- 23 Mar 2020
- Start date
- 8 Sept 2020
- Primary completion date
- 11 Sept 2024
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Diseases
- Colorectal cancer
- NCT number
- NCT04323722
What you commit to
- Study type: Interventional
- Participants enrolled: 53
- From 8 Sept 2020 to the primary completion date, 11 Sept 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous treatment with pelvic radiotherapy
Other illness
- Chronic inflammatory bowel disease in flare-up.
- History of prostatectomy, or hysterectomy
Other
- Urinary catheterization, urinary diversion or cystectomy
- Hip prosthesis
- Urinary incontinence \> 2
- Pregnant or nursing patient
- Persons deprived of their liberty, as well as adults subject to a legal protection measure
- Impossibility to submit to the medical follow-up of this clinical trial for geographical, social or psychological reasons
Who the study is looking for
- Histologically confirmed rectal adenocarcinoma
- T2 N+ or T3 any N, eligible for radiotherapy or neo-adjuvant radio-chemotherapy treatment in a long course of 25 fractions
- Performance Status less or equal to 2
- Male or female 18 Years and older
- Creatinine clearance greater than or equal to 50ml/min
- Fertile patients must use effective contraception
- Written informed consent
- Patient must be affiliated to a Social Health Insurance
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Cacerologie de l'ouest - site Paul Papin Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| Ico Rene Gauducheau Coordinator of this site? Confirm its status | Saint-Herblain | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.